{Reference Type}: Journal Article
{Title}: Mitochondrial control of hypoxia-induced pathological retinal angiogenesis.
{Author}: Yagi H;Boeck M;Nian S;Neilsen K;Wang C;Lee J;Zeng Y;Grumbine M;Sweet IR;Kasai T;Negishi K;Singh SA;Aikawa M;Hellström A;Smith LEH;Fu Z;
{Journal}: Angiogenesis
{Volume}: 0
{Issue}: 0
{Year}: 2024 Aug 3
{Factor}: 10.658
{DOI}: 10.1007/s10456-024-09940-w
{Abstract}: OBJECTIVE: Pathological retinal neovascularization is vision-threatening. In mouse oxygen-induced retinopathy (OIR) we sought to define mitochondrial respiration changes longitudinally during hyperoxia-induced vessel loss and hypoxia-induced neovascularization, and to test interventions addressing those changes to prevent neovascularization.
METHODS: OIR was induced in C57BL/6J mice and retinal vasculature was examined at maximum neovessel formation. We assessed total proteome changes and the ratio of mitochondrial to nuclear DNA copy numbers (mtDNA/nDNA) of OIR vs. control retinas, and mitochondrial oxygen consumption rates (OCR) in ex vivo OIR vs. control retinas (BaroFuse). Pyruvate vs. vehicle control was supplemented to OIR mice either prior to or during neovessel formation.
RESULTS: In OIR vs. control retinas, global proteomics showed decreased retinal mitochondrial respiration at peak neovascularization. OCR and mtDNA/nDNA were also decreased at peak neovascularization suggesting impaired mitochondrial respiration. In vivo pyruvate administration during but not prior to neovessel formation (in line with mitochondrial activity time course) suppressed NV.
CONCLUSIONS: Mitochondrial energetics were suppressed during retinal NV in OIR. Appropriately timed supplementation of pyruvate may be a novel approach in neovascular retinal diseases.